Prediabetic markers in children with stress hyperglycemia

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 9, 1996, Pages 936-941

  Bhisitkul, Donna M ^a   Vinik, Aaron I ^b   Morrow, Ardythe L ^a   She, Jin Xiong ^c   Shults, Justine ^a   Powers, Alvin C ^d,e   Maclaren, Noel K ^c  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUCOSE; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC MARKER; HLA TYPING; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STRESS;

EID: 0029829987     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170340050010     Document Type: Article

References (25)

1. Bhisitkul DM, Morrow AL, Vinik AI, Shutts J, Layland JC, Rohn R. Prevalence of stress hyperglycemia among patients attending a pediatric emergency department. J Pediatr. 1994;124:547-551.
2. Vardi P, Shehade N, Etzoni A, et al. Stress hyperglycemia in childhood: a very high risk group for the development of type I diabetes. J Pediatr. 1990;117: 75-77.
3. Herskowitz RD, Wolfsdorf JI, Ricker AT, et al. Transient hyperglycemia in childhood: identification of a subgroup with: imminent diabetes mellitus. Diabetes Res. 1988;9:161-167.
4. Schatz DA, Kowa H, Winter WE, et al. Natural history of incidental hyperglycemia and glycosuria of childhood. J Pediatr. 1989;115:676-680.
5. Herskowitz-Dumont R, Wolfsdorf JI, Jackson RA, Eisenbarth GS. Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr. 1993;123:347-354.
6. Neufeld M, Maclaren NK, Riley WJ, Lezotte DC, Silverstein JH, Rosenbloom AL. Islet cell and other organ-specific antibodies in U.S. Caucasians and blacks with insulin-dependent diabetes mellitus. Diabetes. 1980;29:589-592.
7. Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods. 1988;106:83-88.
8. Gleichmann H, Bottazzo GF. Progress toward standardization of cytoplasmic islet cell antibody assay. Diabetes. 1987;36:578-584.
9. Bruining GJ, Molenaar JL, Grobbee DE, et al. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet. 1989;1:1100-1103.
10. Bonifacio E, Bingley PJ, Shattock M, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 1990;335:147-149.
11. Riley WJ, Maclaren NK, Krischer J, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med. 1990;323:1167-1172.
12. Vardi P, Dib SA, Tuttleman M, et al. Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes. 1987;36:1286-1291.
13. Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes. 1986;35:894-898.
14. Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes. 1994;43:968-975.
15. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrrison LC. Participating laboratories: high level of concordance between assays for glutamic acid decarboxylase antibodies: the first International Glutamic Acid Decarboxylase Antibody Workshop. Diabetes. 1994;43:1005-1009.
16. She JX, Bui MM, Tian XH, et al. Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity. 1994;18: 195-203.
17. Cudworth AG, Wolf E. The genetic susceptibility to type I (insulin-dependent) diabetes mellitus. Clin Endocrinol Metab. 1982;11:389-407.
18. Thornsby E, Ronningen KS. Role of HLA genes in predisposition to develop insulin-independent diabetes mellitus. Ann Med. 1992;24:523-531.
19. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:371-377.
20. Wasserfall C, Schatz D, Mehta HB, et al. Glutamic acid decarboxylase autoantibodies measured by ELISA powerfully predict impending IDD in the general population. Diabetes. 1995;44:77A. Abstract.
21. Roll U, Christie MR, Fuchtenbusch M, Ziegler AG. Antibodies to GAD are not the first that appear in life in offspring of diabetic mothers or fathers, but are of value for the prediction of type I diabetes. Diabetes. 1995;44:77A. Abstract.
22. Yu L, Gianani R, Verge CF, Chase P, Eisenbarth GS. Unique correlation of anti-insulin autoantibodies with age of diabetes onset and progress to type I diabetes. Diabetes. 1995;44:77A. Abstract.
23. Diabetes Epidemiology Research International Mortality Study Group. Major cross-country differences in risk of dying for people with IDDM. Diabetes Care. 1991;14:49-54.
24. Shah S, Benaim E, Benaim E, Hvizdala E, Griggs S. Insulin auto-antibodies may be an indication of beta cell destruction rather than autoimmunity in insulin dependent diabetes mellitus. J Diabetes. 1993;42:64A. Abstract.
25. Reid HL, Dimitrios P, Photiades DP, Oli JM, Kaine W. Concurrent sickle cell disease and diabetes mellitus. Trop Geogr Med 1988;40:201-204.